The goal of growth hormone (GH) treatment in a short child is to attain a fast catch-up growth
toward the target height (TH) standard deviation score (SDS), followed by a maintenance …

Objetivo: Apresentar os principais resultados dos estudos que investigaram polimorfismos
genéticos em síndrome de Turner, bem como sua associação com alguns sinais clínicos e …

Context: Mutations in the immunoglobulin superfamily, member 1 (IGSF1) gene cause the X-
linked IGSF1 deficiency syndrome consisting of central hypothyroidism, delayed pubertal …

Serum insulin-like growth factor-1 (IGF-I) and IGF binding protein-3 (IGFBP-3) levels can be
used to monitor the safety of recombinant human growth hormone (rhGH) therapy. In this …

Background: There is great interindividual variability in the response to GH therapy.
Ascertaining genetic factors can improve the accuracy of growth response predictions …

Turner syndrome (TS) affects 50 per 100 000 females. TS affects multiple organs through all
stages of life, necessitating multidisciplinary care. This guideline extends previous ones and …

The process of growth is complex and is influenced by various factors that act centrally and
peripherally. The genetic control of human growth is becoming increasingly clear. Many …

Most patients with Turner Syndrome (TS) need hormone replacement therapy because of
hypergonadotropic hypogonadism; individual outcomes, however, are highly variable. Our …

Objetivo: Apresentar os principais resultados dos estudos que investigaram polimorfismos
genéticos em síndrome de Turner, bem como sua associação com alguns sinais clínicos e …

Objective: The aim was to evaluate the results of diagnosis, follow-up and treatment of the
patients who recieved growth hormone (GH) treatment for the last 10 years and to determine …